{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:51:14Z","timestamp":1762876274759,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.endinu.2020.07.012","type":"journal-article","created":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T06:45:33Z","timestamp":1608878733000},"page":"567-572","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Real-world effectiveness and safety of sensor-augmented insulin pump therapy in adults with type 1 diabetes: Long-term follow-up"],"prefix":"10.1016","volume":"68","author":[{"given":"Nicol\u00e1s","family":"Coronel-Restrepo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edctor Manuel","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andres","family":"Palacio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Ram\u00edrez-Rinc\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebasti\u00e1n","family":"Arbel\u00e1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Duque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jos\u00e9","family":"Pino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Carvajal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Bedoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana Paola","family":"Cuesta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Fernando","family":"Botero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.endinu.2020.07.012_bib0155","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00125-008-0974-3","article-title":"Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis","volume":"51","author":"Jeitler","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.endinu.2020.07.012_bib0160","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00592-009-0132-5","article-title":"Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysis","volume":"47","author":"Monami","year":"2010","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.endinu.2020.07.012_bib0165","doi-asserted-by":"crossref","first-page":"336","DOI":"10.7326\/0003-4819-157-5-201209040-00508","article-title":"Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis","volume":"157","author":"Yeh","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.endinu.2020.07.012_bib0170","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1210\/jc.2010-2756","article-title":"Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline","volume":"96","author":"Klonoff","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2020.07.012_bib0175","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1210\/jc.2016-2534","article-title":"Diabetes technology-continuous subcutaneous insulin infusion therapy and continuous glucose monitoring in adults: an endocrine society clinical practice guideline","volume":"101","author":"Peters","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2020.07.012_bib0180","first-page":"1008","article-title":"Continuous glucose monitoring: a consensus conference of the American Association ff Clinical Endocrinologists and American College of Endocrinology","volume":"22","author":"Fonseca","year":"2016","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"key":"10.1016\/j.endinu.2020.07.012_bib0185","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.2337\/dc20-S007","article-title":"7. Diabetes technology: standards of medical care in diabetes \u2013 2020","volume":"43","author":"American Diabetes Association","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.endinu.2020.07.012_bib0190","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1002853","article-title":"Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes","volume":"363","author":"Bergenstal","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.endinu.2020.07.012_bib0195","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1089\/dia.2011.0084","article-title":"Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy","volume":"13","author":"Danne","year":"2011","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.endinu.2020.07.012_bib0200","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/dia.2012.0288","article-title":"Routine sensor-augmented pump therapy in type 1 diabetes: the INTERPRET study","volume":"15","author":"N\u00f8rgaard","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.endinu.2020.07.012_bib0205","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1089\/dia.2016.0171","article-title":"Comparison of different treatment modalities for type 1 diabetes. Including sensor-augmented insulin regimens, in 52 weeks of follow-up: a COMISAIR study","volume":"18","author":"\u0160oupal","year":"2016","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.endinu.2020.07.012_bib0210","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2337\/dc19-0888","article-title":"Glycemic outcomes in adults with T1D are impacted more by continuous glucose monitoring than by insulin delivery method: 3 years of follow-up from the COMISAIR study","volume":"43","author":"\u0160oupal","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.endinu.2020.07.012_bib0215","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1089\/dia.2016.0166","article-title":"Clinical outcomes after 1 year of augmented insulin pump therapy in patients with diabetes in a specialized diabetes center in Medell\u00edn, Colombia","volume":"18","author":"Ramirez-Rincon","year":"2016","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.endinu.2020.07.012_bib0220","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.avdiab.2013.04.001","article-title":"Factores asociados con el control gluc\u00e9mico \u00f3ptimo en pacientes tratados con bomba de insulina y monitorizaci\u00f3n continua de glucosa en tiempo real","volume":"29","author":"G\u00f3mez","year":"2013","journal-title":"Av En Diabetol"},{"key":"10.1016\/j.endinu.2020.07.012_bib0225","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/dia.2016.0332","article-title":"Long-term efficacy and safety of sensor augmented insulin pump therapy with low-glucose suspend feature in patients with type 1 diabetes","volume":"19","author":"G\u00f3mez","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.endinu.2020.07.012_bib0230","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1016\/j.dsx.2019.07.024","article-title":"Impact of sensor-augmented pump therapy with predictive low-glucose management on hypoglycemia and glycemic control in patients with type 1 diabetes mellitus: 1-year follow-up","volume":"13","author":"G\u00f3mez","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.endinu.2020.07.012_bib0235","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2147\/JMDH.S160029","article-title":"Real world data: an opportunity to supplement existing evidence for the use of long-established medicines in health care decision making","volume":"11","author":"Katkade","year":"2018","journal-title":"J Multidiscip Healthc"},{"key":"10.1016\/j.endinu.2020.07.012_bib0240","doi-asserted-by":"crossref","first-page":"111","DOI":"10.12688\/f1000research.13585.2","article-title":"Real world evidence (RWE) \u2013 a disruptive innovation or the quiet evolution of medical evidence generation?","volume":"7","author":"Khosla","year":"2018","journal-title":"F1000Research"},{"key":"10.1016\/j.endinu.2020.07.012_bib0245","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMp1712001","article-title":"Medical devices in the real world","volume":"378","author":"Resnic","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.endinu.2020.07.012_bib0250","first-page":"CD008101","article-title":"Continuous glucose monitoring systems for type 1 diabetes mellitus","volume":"1","author":"Langendam","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.endinu.2020.07.012_bib0255","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1089\/dia.2018.0199","article-title":"Impact of sensor-augmented pump therapy with predictive low-glucose suspend function on glycemic control and patient satisfaction in adults and children with type 1 diabetes","volume":"20","author":"Beato-V\u00edbora","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.endinu.2020.07.012_bib0260","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S2213-8587(19)30150-0","article-title":"Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial","volume":"7","author":"Bosi","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.endinu.2020.07.012_bib0265","doi-asserted-by":"crossref","first-page":"107989","DOI":"10.1016\/j.diabres.2019.107989","article-title":"Effect of frequency of sensor use on glycaemic control in individuals on sensor-augmented pump therapy with and without Predictive Low Glucose Management System","volume":"159","author":"Abraham","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.endinu.2020.07.012_bib0270","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1136\/bmj.325.7367.746","article-title":"Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial","volume":"325","author":"DAFNE Study Group","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.endinu.2020.07.012_bib0275","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.diabres.2010.03.017","article-title":"Long-term biomedical and psychosocial outcomes following DAFNE (Dose Adjustment For Normal Eating) structured education to promote intensive insulin therapy in adults with sub-optimally controlled Type 1 diabetes","volume":"89","author":"Speight","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.endinu.2020.07.012_bib0280","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2337\/dc11-1579","article-title":"Improved biomedical and psychological outcomes 1 year after structured education in flexible insulin therapy for people with type 1 diabetes: the U.K. DAFNE experience","volume":"35","author":"Hopkins","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.endinu.2020.07.012_bib0285","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1464-5491.2011.03525.x","article-title":"Glycaemic control and weight 7 years after Dose Adjustment For Normal Eating (DAFNE) structured education in Type 1 diabetes","volume":"29","author":"Gunn","year":"2012","journal-title":"Diabet Med J Br Diabet Assoc"},{"key":"10.1016\/j.endinu.2020.07.012_bib0290","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2337\/dc12-0080","article-title":"Structured type 1 diabetes education delivered within routine care: impact on glycemic control and diabetes-specific quality of life","volume":"36","author":"Cooke","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.endinu.2020.07.012_bib0295","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.2337\/dc18-0917","article-title":"Efficacy of an education program for people with diabetes and insulin pump treatment (INPUT): results from a randomized controlled trial","volume":"41","author":"Ehrmann","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.endinu.2020.07.012_bib0300","first-page":"356","article-title":"Relative effectiveness of insulin pump treatment over multiple daily injections and structured education during flexible intensive insulin treatment for type 1 diabetes: cluster randomised trial (REPOSE)","author":"Group TRS","year":"2017","journal-title":"BMJ"}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530016420302433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530016420302433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:09:35Z","timestamp":1762866575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530016420302433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S2530016420302433"],"URL":"https:\/\/doi.org\/10.1016\/j.endinu.2020.07.012","relation":{},"ISSN":["2530-0164"],"issn-type":[{"type":"print","value":"2530-0164"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world effectiveness and safety of sensor-augmented insulin pump therapy in adults with type 1 diabetes: Long-term follow-up","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endinu.2020.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 SEEN y SED. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}